Abstract
HEPATOCYTE growth factor/scatter factor (HGF/SF) functions as a mitogen, motogen and morphogen for a variety of cultured cells1–7. The genes for HGF/SF and its receptor (the c-met protooncogene product8) are expressed in many tissues during the embryonic periods and in the adult9–14. HGF/SF is thought to mediate a signal exchange between the mesenchyme and epithelia during mouse development15. To examine the physiological role of HGF/SF, we generated mutant mice with a targeted disruption of the HGF/SF gene. Here we report that homozygous mutant embryos have severely impaired placentas with markedly reduced numbers of labyrinthine trophoblast cells, and die before birth. The growth of trophoblast cells was stimulated by HGF/SF in vitro, and the HGF/SF activity was released by allantois in primary culture of normal but not mutant embryos. These findings suggest that HGF/SF is an essential mediator of allantoic mesenchyme-trophoblastic epithelia interaction required for placental organogenesis.
Similar content being viewed by others
References
Gohda, E. et al. J. clin. Invest. 81, 414–419 (1988).
Zarnegar, R. & Michalopoulos, G. Cancer Res. 49, 3314–3320 (1989).
Nakamura, T. et al. Nature 342, 440–443 (1989).
Rubin, J. S. et al. Proc. natn. Acad. Sci. U.S.A. 88, 415–419 (1991).
Stoker, M., Gherardi, E., Perryman, M. & Gray, J. Nature 327, 239–242 (1987).
Weidner, K. M. et al. Proc. natn. Acad. Sci. U.S.A. 88, 7001–7005 (1991).
Montesano, R., Matsumoto, K., Nakamura, T. & Orci, L. Cell 67, 901–908 (1991).
Bottaro, D. P. et al. Science 251, 802–804 (1991).
Miyazawa, K. et al. Biochem. biophys. Res. Commun. 163, 967–973 (1989).
Tashiro, K. et al. Proc. natn. Acad. Sci. U.S.A. 87, 3200–3204 (1990).
Defrances, M. C., Wolf, H. K., Michalopoulos, G. K. & Zarnegar, R. Development 116, 387–395 (1992).
Chan, A. M.-L. et al. Oncogene 2, 593–599 (1988).
Iyer, A. et al. Cell Growth Differ. 1, 87–95 (1990).
Di Renzo, M. F. et al. Oncogene 6, 1997–2003 (1991).
Sonnenberg, E., Meyer, D., Weidner, K. M. & Birchmeier, C. J. Cell Biol. 123, 223–235 (1993).
Okigaki, M., Komada, M., Uehara, Y., Miyazawa, K. & Kitamura, N. Biochemistry 31, 9555–9561 (1992).
Schmidt, C. et al. Nature 373, 699–702 (1995).
Muntener, M. & Hsu, Y.-C. Acta anat. 98, 241–252 (1977).
Garbis-Berkvens, J. M. & Peters, P. W. J. in Pharmacokinetics in Teratogenesis: I (eds Nau, H. & Scott, W. J. J.) 13–44 (CRC, Boca Raton, 1987).
Peel, S. & Bulmer, D. J. Anat. 124, 675–687 (1977).
Rossant, J. & Tamura-Lis, W. J. Embryol. exp. Morph. 62, 217–227 (1981).
Barlow, P. W. & Sherman, M. I. J. Embryol. exp. Morphol. 27, 447–465 (1972).
Bussolino, F. et al. J. Cell Biol. 119, 629–641 (1992).
Grant, D. S. et al. Proc. natn. Acad. Sci. U.S.A. 90, 1937–1941 (1993).
Rudnicki, M. A., Braun, T., Hinuma, S. & Jaenisch, R. Cell 71, 383–390 (1992).
Okajima, A., Miyazawa, K. & Kitamura, N. Eur. J. Biochem. 193, 375–381 (1990).
Li, E., Bestor, T. H. & Jaenisch, R. Cell 69, 915–926 (1992).
Takeshima, H. et al. Nature 369, 556–559 (1994).
Bradley, A. in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (eds Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Uehara, Y. & Kitamura, N. J. Cell Biol. 117, 889–894 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uehara, Y., Minowa, O., Mori, C. et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702–705 (1995). https://doi.org/10.1038/373702a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/373702a0
- Springer Nature Limited
This article is cited by
-
Deficiency of the HGF/Met pathway leads to thyroid dysgenesis by impeding late thyroid expansion
Nature Communications (2024)
-
Hypoxic stress disrupts HGF/Met signaling in human trophoblasts: implications for the pathogenesis of preeclampsia
Journal of Biomedical Science (2022)
-
When the MET receptor kicks in to resist targeted therapies
Oncogene (2021)
-
Human placental extract attenuates neurological symptoms in the experimental autoimmune encephalomyelitis model of multiple sclerosis-a putative approach in MS disease?
Autoimmunity Highlights (2020)
-
A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
Nature Communications (2020)